22
Participants
Start Date
June 1, 2024
Primary Completion Date
May 20, 2025
Study Completion Date
January 10, 2026
Coenzyme Q10
"100 mg once daily starting after the first chemotherapy cycle. Patients will receive 12 cycles of the modified FOLFOX-6 regimen with Coenzyme Q10 (100 mg once daily in the morning), starting after the first chemotherapy cycle and continuing until the end of the 12th cycle. Based on McRae (2023), 200 mg/day for 12 weeks reduced TNF-α and IL-6; thus, 100 mg/day for 6 months was selected (one cycle every 2 weeks = 24 weeks).~Supportive care: Includes a 5-HT3 antagonist for nausea prevention and pantoprazole to prevent gastric irritation.~Intervention Details:~Oxaliplatin: Part of the FOLFOX-6 regimen. 5-Fluorouracil (5-FU): Part of the FOLFOX-6 regimen. Leucovorin: Part of the FOLFOX-6 regimen. 5-HT3 Antagonist: Used for nausea prevention. Pantoprazole: Used to prevent gastric irritation."
Oxaliplatin
Part of the modified FOLFOX-6 chemotherapy regimen
5-Fluorouracil (5-FU)
Part of the modified FOLFOX-6 chemotherapy regimen.
5-HT3 Antagonist
Used for nausea prevention during chemotherapy.
Pantoprazole
Used to prevent gastric irritation during chemotherapy
RECRUITING
Ain-Shams University Hospital, Cairo
toqa saad mohammed mohammed
OTHER